Regenxbio Inc.
Get Full AccessDescription
- REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and thirdparty NAV Technology Platform licensees.
-
Headquarters:9600 Blackwell Rd Ste 210 Suite 210, Rockville, Maryland, United States
More -
Phone Number: +1 240-552-8181
-
Website: https://www.regenxbio.com
-
Employees:274
-
Revenue:$250 - 500M
-
Legal Name:Regenxbio Inc.
-
Regenxbio Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541714 |
Show More
Frequently Asked Questions regarding Regenxbio Inc.
-
Where are Regenxbio Inc.'s Headquarters?
Regenxbio Inc.'s Headquarters are in 9600 Blackwell Rd Ste 210 Suite 210,Rockville,Maryland,United States
-
What is Regenxbio Inc.'s phone number?
Regenxbio Inc.'s phone number is +1 240-552-8181
-
What is Regenxbio Inc.'s official website?
Regenxbio Inc.'s official website is https://www.regenxbio.com
-
What is Regenxbio Inc.'s Revenue?
Regenxbio Inc.'s revenue is $250 - 500M
-
What is Regenxbio Inc.'s NAICS code?
Regenxbio Inc.'s NAICS code is 541714
-
How many employees are working in Regenxbio Inc.
Regenxbio Inc. has 274 employees
-
What is Regenxbio Inc.'s Industry?
Regenxbio Inc. is in the industry of Biotechnology
-
Who is Regenxbio Inc.'s Vice President, Corporate Development?
Regenxbio Inc.'s Vice President, Corporate Development is Andrew Yost

